0 NASDAQ Companies - June 14, 2019TLC Announces Part 1 Analysis of TLC590 Phase II Clinical Trial for Postsurgical Pain Management following BunionectomyRead More
0 NASDAQ Companies - June 14, 2019Chi-Med Announces that Surufatinib Phase III SANET-ep Study Has Met its Primary Endpoint at Interim Analysis in Advanced Non-Pancreatic Neuroendocrine Tumors in China and Will Stop EarlyRead More
0 NYSE Companies - June 14, 2019Philips Research wins Dutch Hendrik Lorentz Award for its pioneering use of data science and artificial intelligence in healthcareRead More
0 NASDAQ Companies - June 14, 2019GBT Announces Updated 24-Week Efficacy Data from All Patients Enrolled in Phase 3 HOPE Study Showing Statistically Significant and Sustained Improvements in Hemoglobin with VoxelotorRead More
0 NYSE Companies - June 14, 2019Novartis continues to innovate in CML with long-term treatment-free remission results following Tasigna® use and promising combination data with investigational compound asciminib (ABL001)Read More
0 NASDAQ Companies - June 14, 2019BeiGene Announces Clinical Results from Three Posters on Zanubrutinib Presented at the 24th Congress of European Hematology Association (EHA)Read More
0 NASDAQ Companies - June 14, 2019BeiGene Announces Updated Results from a Pivotal Phase 2 Study of Tislelizumab in Chinese Patients with Relapsed or Refractory Classical Hodgkin Lymphoma at the 24th Congress of the European Hematology Association (EHA)Read More
0 NYSE Companies - June 14, 2019Fca Signs Partnerships with ENEL X and ENGIE group for New E-Mobility SolutionsRead More
0 NASDAQ Companies - June 14, 2019Align Technology and Straumann Group Terminate Discussions Concerning a Possible Development and Distribution AgreementRead More
